1. Gilliam JN, Sontheimer RD. Distinctive cutaneous subsets in the spectrum of lupus erythematosus. J Am Acad Dermatol. 1981;4:471–5.
2. Werth VP. Clinical manifestations of cutaneous lupus erythematosus. Autoimmun Rev. 2005;4:296–302.
3. Lee HJ, Sinha AA. Cutaneous lupus erythematosus: understanding of clinical features, genetic basis, and pathobiology of disease guides therapeutic strategies. Autoimmunity. 2006;39:433–44.
4. •• Fett N, Werth VP (2011, In press) Treatment of cutaneous lupus erythematosus. In: Maibach H, editor. Evidence Based Dermatology. 2nd ed. This is a thorough, evidence-based review of treatments used in CLE. It addresses treatment efficacy by focusing on level of evidence as well as study design and outcome measures. It includes a focused summary section on the level of evidence for different treatments used.
5. •• Kuhn A, Ruland V, Bonsmann G (2010) Cutaneous lupus erythematosus: update of therapeutic options part I and part II. J Am Acad Dermatol. This is a comprehensive and detailed two-part review of treatment options, including details on CLE subtypes and medication dosing used in studies. It provides a diagrammatic treatment algorithm.